Advertisement
Advertisement

INO

INO logo

Inovio Pharmaceuticals, Inc.

1.11
USD
Sponsored
+0.01
+0.91%
Jun 16, 15:58 UTC -4
Closed
exchange

After-Market

1.10

-0.01
-0.45%

INO Earnings Reports

Positive Surprise Ratio

INO beat 20 of 42 last estimates.

48%

Next Report

Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.24
Implied change from Q1 26 (Revenue/ EPS)
--
/
-14.29%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-60.66%

Inovio Pharmaceuticals, Inc. earnings per share and revenue

On May 13, 2026, INO reported earnings of -0.28 USD per share (EPS) for Q1 26, beating the estimate of -0.35 USD, resulting in a 20.79% surprise. Revenue reached --, compared to an expected 252.50 thousand, with a -100.00% difference. The market reacted with a +1.49% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.24 USD, with revenue projected to reach -- USD, implying an decrease of -14.29% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, Inovio Pharmaceuticals, Inc. reported EPS of -$0.28, beating estimates by 20.79%, and revenue of $0.00, -100% below expectations.
The stock price moved up 1.49%, changed from $1.34 before the earnings release to $1.36 the day after.
The next earning report is scheduled for Aug 10, 2026.
Based on 4 analysts, Inovio Pharmaceuticals, Inc. is expected to report EPS of -$0.24 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement